Single-cell RNA-sequencing analysis of patient tumor-infiltrating lymphocytes revealed that CXCR3 was expressed by CD8+ and CD4+ T cells, whilst CXCL9 and CXCL10 were predominantly expressed by macrophages following dual ICI treatment [117]. The gene discussed is CXCL9; the disease is neoplasm.